Solupharm Ltd.

Solupharm Limited UK is a consultancy and contract research operation, specialising in the pharmacology of multiple sclerosis, experimental autoimmune encephalomyelitis and uveoretinitis.

Solupharm is dedicated to drug evaluation and efficacy in experimental model systems of multiple sclerosis and operates from laboratory facilities in London.

Director, Dr Chris Bolton, Ph.D. provides extensive knowledge and expertise in the pharmacology of immune and non-immune inflammatory states, gained in both the industrial and academic sectors.

Dr Bolton gained his first degree in Applied Biology from the University of Hertfordshire and an M.Sc. in Biochemistry from University College, London. He was awarded a Ph.D. for his studies on the pharmacological control of demyelinating diseases and, in particular, the human condition, multiple sclerosis.